NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637139. A total of 13 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Values First Advisors, Inc. | 26,682 | $46,610 | 0.03% |
| Frazier Life Sciences Management, L.P. | 17,025 | $29,741 | 0.00% |
| ROYAL BANK OF CANADA | 20 | $0 | 0.00% |
| UBS Group AG | 1,315 | $2,297 | 0.00% |
| OSAIC HOLDINGS, INC. | 2,008 | $3,214 | 0.00% |
| FMR LLC | 400 | $692 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 84 | $147 | 0.00% |
| WELLS FARGO & COMPANY/MN | 40 | $70 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 4,108 | $7,176 | 0.00% |